APA

Ramires F. J. A., Martinez F., Gómez E. A., Demacq C., Gimpelewicz C. R., Rouleau J. L., Solomon S. D., Swedberg K., Zile M. R., Packer M. & McMurray J. J. V. (20181231). Post hoc analyses of SHIFT and PARADIGM-HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: "Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial" by Bocchi et al. : ESC heart failure.

Chicago

Ramires Felix J A, Martinez Felipe, Gómez Efraín A, Demacq Caroline, Gimpelewicz Claudio R, Rouleau Jean L, Solomon Scott D, Swedberg Karl, Zile Michael R, Packer Milton and McMurray John J V. 20181231. Post hoc analyses of SHIFT and PARADIGM-HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: "Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial" by Bocchi et al. : ESC heart failure.

Harvard

Ramires F. J. A., Martinez F., Gómez E. A., Demacq C., Gimpelewicz C. R., Rouleau J. L., Solomon S. D., Swedberg K., Zile M. R., Packer M. and McMurray J. J. V. (20181231). Post hoc analyses of SHIFT and PARADIGM-HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: "Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial" by Bocchi et al. : ESC heart failure.

MLA

Ramires Felix J A, Martinez Felipe, Gómez Efraín A, Demacq Caroline, Gimpelewicz Claudio R, Rouleau Jean L, Solomon Scott D, Swedberg Karl, Zile Michael R, Packer Milton and McMurray John J V. Post hoc analyses of SHIFT and PARADIGM-HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: "Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial" by Bocchi et al. : ESC heart failure. 20181231.